Printed From BioPortfolio.com
#JPM19 Conference: Lilly Announces Agreement To Acquire Loxo Oncology
09:15 EST 8 Jan 2019 | Leaders in Pharmaceutical Business Intelligence
News announced during the 37th J.P. Morgan Healthcare Conference (#JPM19): Drugmaker Eli Lilly and Company announced its plans to acquire Loxo for $8 billion, as part of its oncology strategy, which focuses “opportunities for first-in-class and best-in-class therapies.” Reporter: Gail S. Thornton Please read their press release below. INDIANAPOLIS and STAMFORD, Conn., Jan. 7, 2019 /PRNewswire/ — Acquisition will […]
Original Article: #JPM19 Conference: Lilly Announces Agreement To Acquire Loxo Oncology
